Report overview
The CRISPR-Cas technology is a?versatile genome editing tool?that has been used to improve agriculturally important crop traits, such as quality, disease resistance, and herbicide tolerance.
This report aims to provide a comprehensive presentation of the global market for CRISPR in 569, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRISPR in 569. This report contains market size and forecasts of CRISPR in 569 in global, including the following market information:
Global CRISPR in 569 Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global CRISPR in 569 market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Crops Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of CRISPR in 569 include Arcadia Biosciences, Bayer AG, BASF SE, Beam Therapeutics Inc., Benson Hill Biosystems, Inc., Caribou Bioscience Inc., Calyxt, Inc., Cellectis SA and Cibus, Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the CRISPR in 569 companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global CRISPR in 569 Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global CRISPR in 569 Market Segment Percentages, by Type, 2022 (%)
Crops
Livestock
Aquaculture
Global CRISPR in 569 Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global CRISPR in 569 Market Segment Percentages, by Application, 2022 (%)
Academic & Research Institutes
Biotech Companies
Global CRISPR in 569 Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global CRISPR in 569 Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies CRISPR in 569 revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies CRISPR in 569 revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Arcadia Biosciences
Bayer AG
BASF SE
Beam Therapeutics Inc.
Benson Hill Biosystems, Inc.
Caribou Bioscience Inc.
Calyxt, Inc.
Cellectis SA
Cibus, Ltd.
CRISPR Therapeutics AG
DeciBio, LLC
E. I. du Pont de Nemours and Co.
Evogene Ltd.
GeneCopoeia inc.
Horizon Discovery Group PLC
Intellia Therapeutics, Inc.
J.R. Simplot Co.
Pairwise Plants
Synthetic Genomics Inc.
Tropic Biosciences UK LTD.
Yield10 Bioscience, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of CRISPR in 569, market overview.
Chapter 2: Global CRISPR in 569 market size in revenue.
Chapter 3: Detailed analysis of CRISPR in 569 company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of CRISPR in 569 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
